Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Bernard Coulie
|
| gptkbp:developedBy |
small molecule therapeutics
|
| gptkbp:focusesOn |
oncology
fibrotic diseases |
| gptkbp:foundedYear |
2016
|
| gptkbp:founder |
gptkb:Brad_Bolzon
Bernard Coulie Dean Sheppard Hal Chapman William DeGrado |
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pliant Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
PLN-1474
PLN-74809 |
| gptkbp:specializesIn |
integrin biology
|
| gptkbp:stockSymbol |
PLRX
|
| gptkbp:target |
gptkb:nonalcoholic_steatohepatitis_(NASH)
idiopathic pulmonary fibrosis primary sclerosing cholangitis |
| gptkbp:website |
https://www.pliantrx.com/
|
| gptkbp:bfsParent |
gptkb:South_San_Francisco,_California,_USA
|
| gptkbp:bfsLayer |
7
|